Obese pregnant women have higher rates of dysfunctional labor patterns, need for oxytocin augmentation, labor induction, postdates pregnancy, and cesarean delivery compared to normal weight pregnant women. We tested the hypothesis that myometrial oxytocin receptor (OXTR) gene and protein expression are affected by obesity in pregnancy. Myometrial samples were obtained at the time of cesarean delivery from the upper aspect of the uterine hysterotomy incision and processed for realtime quantitative polymerase chain reaction and Western blot. There were 63 myometrial samples available for analysis. The median body mass index (BMI) at delivery was 31.0 kg/m 2 (interquartile range, 26.0, 40.0 kg/m 2 ), and the median gestational age at delivery was 38.0 weeks (interquartile range, 33.0, 39.1 weeks). The OXTR gene expression did not correlate with maternal BMI at delivery by linear regression, and the median OXTR gene expression did not differ between women with a BMI 30 kg/m 2 and those with a BMI ! 40 kg/m 2 . The OXTR protein expression was also not affected by maternal BMI. Myometrial OXTR gene expression appears to be independent of BMI at the time of delivery. Dysfunctional labor patterns and increased oxytocin utilization seen in obese women may not be due to differences in OXTR expression, though functional studies are required.
Introduction
Obesity is a significant public health issue in the United States and is a source of substantial morbidity and mortality. In 2009 to 2010, 35.8% of the adult US women were found to be obese, and the number of pregnant women who are obese is increasing. [1] [2] [3] In addition to being at risk of medical complications in pregnancy such as diabetes, hypertension, and preeclampsia, obese women are at significant risk of labor abnormalities and cesarean delivery. 4, 5 Labor abnormalities common among obese women include dysfunctional labor patterns, prolonged latent and active phases of the first stage of labor, greater need of oxytocin augmentation, postterm pregnancy, and cesarean delivery. [6] [7] [8] [9] [10] [11] Labor abnormalities seen in obese women may be due to inadequate myometrial contraction patterns or decreased responsiveness to oxytocin.
The assessment of uterine contractility among obese women has demonstrated conflicting results. Zhang et al tested the strength and frequency of uterine contraction in myometrial strips isolated from obese and nonobese women undergoing planned elective cesarean delivery. They found that myometrial strips from obese women contracted less frequently and with less force compared to myometrial strips obtained from nonobese women. 12 In contrast, another in vitro study comparing contraction strength and frequency of myometrial tissue strips from obese women compared to nonobese women demonstrated no differences between the 2 groups. 13 Similarly, in an in vivo study Chin et al found that though obese women had prolonged labor compared to nonobese women, obese women generated similar strength of uterine contraction during labor, measured by intrauterine pressure assessment (Montevideo units), when compared to nonobese women. 9 Oxytocin signaling is an important mediator of uterine contractility in labor.
14 Altered expression of myometrial oxytocin receptor (OXTR) could potentially contribute to dysfunctional labor patterns and greater need for oxytocin augmentation in obese women. Therefore, our objective was to determine whether myometrial OXTR gene and protein expression are affected by maternal obesity and thus a function of maternal body mass index (BMI) at delivery.
Materials and Methods

Tissue Collection and Quantitative Real-Time PCR
To determine whether myometrial OXTR gene expression correlated with maternal BMI, quantitative real-time polymerase chain reaction (PCR) was performed. Myometrial samples had been previously collected at the time of cesarean delivery and stored as part of the Duke University institutional review board-approved protocol, and Duke Pregnancy Outcomes Blood and Tissue Repository were identified. The myometrial samples were pulverized into a powder while keeping the tissue frozen in liquid nitrogen. The homogenized tissue was then collected in TRIzol reagent (Invitrogen, Carlsbad, California), total RNA was extracted using an RNeasy Mini kit (Qiagen, Valencia, California), and RNA concentrations were calculated using the Nanodrop ND-1000 spectrophotometer. A reverse transcription reaction was performed to create complementary DNA (cDNA) using the Superscript III (Invitrogen) first strand synthesis system. Reverse transcription quantitative real-time PCR (RT-PCR) was performed using a Bio-Rad iCycler (Bio-Rad, Hercules, California) and the Taqman Gene Expression Assay (Applied Biosciences, Carlsbad, California), with probes directed against OXTR and glyceraldehyde 3-phosphate dehydrogenase (GAPDH), a housekeeping gene used for normalization of samples (Assay ID Hs00168573_m1 for the OXTR and Assay ID Hs00266705_g1 for GAPDH; Applied Biosystems, Carlsbad, California).
Protein Analysis
To determine whether myometrial OXTR protein expression correlated with maternal BMI, 12 myometrial samples from term, elective cesarean deliveries without labor were randomly selected from the Duke Pregnancy Outcomes Blood and Tissue Repository, 6 from patients with a BMI < 30 kg/m 2 and 6 from patients with a BMI > 40 kg/m 2 . Myometrial tissue was homogenized in cell lysis buffer (Cell Signaling Technologies, Danvers, Massachusetts) and processed for sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) electrophoresis using standard protocols. Western blots were performed using antibodies directed against human OXTR (product number sc-33209; Santa Cruz Biotechnology, Inc, Santa Cruz, CA), after which the blots were stripped and probed for GAPDH (Cell Signaling Technology) as a protein loading control.
Oxytocin binds the OXTR at the plasma membrane, after which, a member of the G protein-coupled receptor kinase family phosphorylates an internal domain of the receptor, allowing for beta-arrestin recruitment to the receptor and receptor internalization and desensitization. 15 The receptor then recycles back to the plasma membrane, where it is then again available for signaling and uterine contraction. 16 Only receptor that is at the plasma membrane is available for oxytocin binding and OXTRmediated uterine contractility. Furthermore, desensitization of the OXTR leads to decreases in uterine contractility that are mediated by beta-arrestin. 17 To determine whether there were differences in the amount of plasma membrane-associated OXTR protein by maternal BMI, plasma membrane preparations (preps) were prepared from the same 12 myometrial samples utilized for the assessment of OXTR protein expression in whole cell lysate. All myometrial samples were from term, unlabored myometrium, 6 from participants with a BMI < 30 kg/m 2 and 6 from participants with a BMI > 40 kg/m C to pellet the nuclear fraction and cellular debris. The supernatant was then collected and spun at 30 000g for 60 minutes at 4 C. The pellet that contained the membrane fraction was resuspended in cell lysis buffer and processed for SDS-PAGE using standard protocols. Western blots were performed using antibodies directed against human OXTR (product number sc-33209; Santa Cruz Biotechnology, Inc,), after which the blots were stripped and probed for caveolin (BD Biosciences, San Jose, California) as a protein loading control. 18 
Statistical Analysis
The RT-PCR was performed from myometrial cDNA obtained for each patient and run in duplicate using TaqMan Gene Expression Probes (Applied Biosystems). For each patient, the mean cycle threshold (CT) values for both OXTR and GAPDH gene expression were obtained. Normalized OXTR gene expression was then reported for each sample using the equation, 2 (OXTR
CT -GAPDH CT)
. Linear regression was used to correlate normalized OXTR gene expression with maternal BMI at delivery. Next, geometric mean and median normalized OXTR gene expression were calculated for women with BMI 30 kg/m 2 and women with BMI > 40 kg/m 2 and the median values compared with a nonparametric t test (Mann-Whitney test).
To compare the relative OXTR protein expression by Western blot, densitometry was performed by measuring the density of the OXTR and the GAPDH bands (or the OXTR and the caveolin bands for the membrane prep experiments) for each sample, and the ratio of the relative density of the OXTR band to the GAPDH (or caveolin) band was calculated. The mean ratios for each of the 2 BMI groups were compared using a nonparametric t test (MannWhitney test). All analyses were performed using GraphPad Prism for Macintosh (GraphPad Prism version 5.0, GraphPad Software, San Diego, California) and JMP for Macintosh (JMP . In all, 46% of the patients were caucasian, the median (quartile) gestational age of delivery was 38.0 (33.0, 39.1) weeks, 60.3% of the patients delivered at greater than or equal to 37 weeks, and 33.3% of the patients labored prior to delivery. All women delivered via cesarean, and 39.7% of the patients had a prior cesarean delivery (Table 1) .
Linear regression demonstrated that myometrial normalized OXTR gene expression obtained from myometrial samples at delivery did not correlate with maternal BMI ( Figure 1A ; r 2 ¼ .023, P ¼ .250). The linear regression analysis was repeated while controlling for labor status and gestational age at delivery. While controlling for labor status and gestational age at delivery, the normalized myometrial OXTR gene expression did not correlate with the maternal BMI at delivery (adjusted analysis, r 2 ¼ .058, P ¼ .227). Also, the median normalized myometrial OXTR gene expression did not differ between women with a BMI of less than 30 kg/m 2 and women with a BMI of greater than 40 kg/m 2 (P ¼ .151; Figure 1B ). Myometrial samples were processed for Western blot to determine whether OXTR protein expression varied by maternal BMI at delivery. Twelve randomly selected myometrial samples were processed for Western blot and probed for OXTR (Figure 2A ). Densitometry demonstrated that the mean relative OXTR protein expression, when normalized to GAPDH as a protein-loading control did not differ between women with a BMI less than 30 kg/m 2 compared to women with a BMI greater than 40 kg/m 2 (P ¼ .938 for difference in mean; Figure 2B ). To determine whether there were differences in the amount of OXTR protein in the myometrial plasma membrane by maternal BMI, plasma membranes were isolated from myometrial samples obtained from 12 patients who delivered at term without labor (6 from women with BMI < 30 kg/m 2 and 6 from women with BMI > 40 kg/m 2 ), processed for Western blot and probed for OXTR ( Figure 2C ). Densitometry demonstrated that the mean relative OXTR protein expression, when normalized to caveolin as a protein-loading control, did not differ between women with a BMI < 30 kg/m 2 and women with a BMI > 40 kg/m 2 (P ¼ .537 for difference in mean; Figure 2D ). Because myometrial OXTR gene expression may be affected by the presence of a uterine scar at the site of repeat hysterotomy, the data were analyzed in women having their first cesarean delivery ( Figure 3A ). There were myometrial samples available from 38 women. Among women having their first cesarean delivery, there was no correlation of normalized OXTR gene expression with maternal BMI (r 2 ¼ .013, P ¼ .450). The median normalized myometrial OXTR gene expression also did not differ between women having a primary cesarean delivery with a BMI of less than 30 kg/m 2 compared to women with a BMI of greater than 40 kg/m 2 (P ¼ .301; Figure 3B ).
Discussion
Obese pregnant women have higher rates of postterm pregnancy, dysfunctional labor patterns, greater need for oxytocin . Plots of normalized OXTR gene expression Â 10 000 (log2 scale) by BMI (linear scale) were constructed. Linear regression was used to compare the normalized OXTR gene expression to maternal BMI at delivery. A, Among all the 63 patients, the OXTR gene expression did not correlate with maternal BMI at delivery (r 2 ¼ .023, P ¼ .250). B, The median myometrial OXTR gene expression at the time of delivery did not differ between nonobese women (BMI 30 kg/m2, n ¼ 27) and obese women (BMI ! 40 kg/m2, n ¼ 14), P ¼ .151 for difference in mean OXTR gene expression by Mann-Whitney test (bars represent geometric mean with 95% confidence interval). The y-axis for each graph represents normalized OXTR gene expression as 2 (OXTR CT -GAPDH CT) Â 10 000 (log2 scale).
augmentation, longer labor, and higher rates of cesarean delivery compared to nonobese women. 6, 8, 10, 12, 19, 20 Inadequate uterine contractility may be a key contributor to these adverse outcomes. Oxytocin receptor signaling is an important component of uterine contractility in labor 14 ; thus, we tested the hypothesis that maternal obesity affects OXTR gene expression, which may explain these adverse events. Contrary to our hypothesis, we demonstrate that myometrial OXTR gene and protein expression determined at the time of delivery does not correlate with maternal BMI.
In vitro myometrial contractility experiments examining the effect of obesity on uterine contraction have produced conflicting results. Zhang et al tested myometrial contraction strength and frequency in myometrial samples obtained from women undergoing term elective cesarean delivery. They found that myometrial strips from obese women contracted less forcefully and less frequently compared to strips obtained from nonobese women. 12 In contrast, Higgins et al, also utilizing myometrial strips obtained from women at the time of cesarean delivery, demonstrated no differences in spontaneous myometrial contraction strength or frequency, or oxytocin-induced contraction strength or frequency, in samples obtained from obese compared to nonobese women. 13 Neither group measured myometrial OXTR mRNA or protein expression; therefore we do not know whether variations in OXTR expression accounted for their findings. Clinically, not all obese women, ultimately requiring cesarean delivery for failed labor, have dysfunctional labor patterns. The mechanism affecting myometrial contractility in obesity may only affect a subset of obese women rather than all. This variation in contractile phenotype may be an explanation for the differences in contractile properties seen in these 2 studies. To determine whether myometrial OXTR protein expression at delivery was influenced by maternal body mass index (BMI), the myometrial samples were obtained from the upper aspect of the hysterotomy incision during cesarean delivery, processed for Western blot, and probed with antibodies directed against the OXTR and GAPDH as a protein-loading control. A, Representative Western blot of myometrial samples obtained from 6 women with BMI < 30 kg/m 2 and from 6 women with BMI > 40 kg/m2. B, Densitometry was used to compare the relative OXTR protein expression between the 2 groups. The relative density of the OXTR band compared to the relative density of the protein-loading control, GAPDH, band was determined for each patient. The mean ratio of OXTR-GAPDH was compared between normal weight and obese groups using the nonparametric Mann-Whiney test. There was no difference in the mean OXTR/GAPDH protein levels between nonobese and obese groups (P ¼ .938, Mann-Whitney nonparametric t test). To determine whether myometrial plasma membrane OXTR protein expression at delivery was influenced by maternal BMI, myometrial samples were obtained from the upper aspect of the hysterotomy incision during cesarean delivery, membrane fractions were isolated, processed for Western blot, and probed with antibodies directed against the OXTR and caveolin as a protein-loading control. C, Representative Western blot of myometrial membrane prep samples obtained from 6 women with BMI < 30 kg/m 2 and from 6 women with BMI > 40 kg/m 2 . D, Densitometry was used to compare the relative OXTR membrane protein expression between the 2 groups. The relative density of the OXTR band compared to the relative density of the protein-loading control, caveolin, band was determined for each patient. The mean ratio of OXTRcaveolin was compared between normal weight and obese groups using the nonparametric Mann-Whiney test. There was no difference in the mean OXTR/caveolin protein levels between normal weight and obese groups (P ¼ .537, Mann-Whitney nonparametric t test).
Abnormal myometrial contractility in obese patients might be due to altered OXTR signaling or associated cofactors instead of differential expression of myometrial OXTR. Leptin and cholesterol have been shown to affect uterine contractility, both of which are commonly elevated in obesity. Furthermore, obese pregnant women have higher levels of serum leptin compared to nonobese pregnant women. 21 In vitro studies demonstrate that both leptin and cholesterol independently led to dose-dependent decreases in spontaneous and oxytocin-induced uterine contractions, though the mechanism by which these findings occur in vitro is unknown. 22, 23 Cholesterol is an important component of the cell membrane and has been shown to stabilize the OXTR within the plasma membrane. 24 Increases in membrane cholesterol levels can affect oxytocin binding to the OXTR and receptor conformation. 25, 26 Furthermore, in other G protein-coupled receptor (GPCR) systems, increases in cell membrane cholesterol content leads to enhanced beta-arrestin-mediated GPCR desensitization. 27 Variations in cell membrane cholesterol levels may affect OXTR binding, signaling, and enhance desensitization, all of which could affect myometrial contractility. Despite the important role of cholesterol in OXTR function, it is unknown whether obesity or dietary cholesterol affects myometrial cell membrane cholesterol levels, which could accordingly alter OXTR signaling.
Myometrial contractile responsiveness to oxytocin correlates with myometrial OXTR expression. 28 Multiple studies have looked at the effect of labor and gestational age on myometrial OXTR gene expression with conflicting results. Some studies report no change in myometrial OXTR expression with labor and gestational age, while others demonstrate increases in OXTR expression with labor and/or gestational age. [29] [30] [31] [32] [33] Steroid hormones and uterine stretch are also important mediators of myometrial OXTR gene expression. 30, 34, 35 We are not aware of any studies attempting to link maternal BMI with myometrial OXTR gene expression, especially in an attempt at explaining why obese women are prone to dysfunctional labor patters. It is possible that myometrial sensitivity to oxytocin may be more important for uterine contractility than absolute myometrial OXTR quantity. 28, 29 Finally, although we did not appreciate differences in absolute OXTR protein expression by maternal BMI in myometrial membrane prep samples, we did not assess OXTR binding. We are unaware of any studies demonstrating variations in GPCR binding by obesity, but future studies are needed to determine whether oxytocin binding to the OXTR is affected by maternal obesity.
We obtained myometrial samples from the lower uterine segment. The OXTR gene expression varies through different regions of the pregnant uterus, where the fundus expresses greater amounts of OXTR compared to the lower uterine segment and cervix. [36] [37] [38] Variations in OXTR density throughout the myometrium may be important in the coordination of contractions from fundus toward cervix. 36 It is possible that fundal expression of OXTR varies with maternal obesity, while lower uterine segment levels remain unaffected by maternal obesity. As our samples were all obtained from the lower uterine segment, we would be unable to detect these differences, if they indeed exist.
In summary, dysfunctional labor patterns manifesting as postterm pregnancy, prolonged labor, increased need for induction or oxytocin augmentation, and increased rates of cesarean delivery are common among obese pregnant women. Adequate uterine contractility is an important aspect of normal labor, though it is unknown whether differences in uterine contractility fully explain dysfunctional labor patterns seen in obesity. Here, we demonstrate that lower uterine segment myometrial OXTR expression does not seem to be a function of maternal BMI. Further molecular studies are needed to understand the mechanism by which some obese women have dysfunctional labor patterns including potential differences in myometrial OXTR cycling and signaling among obese and nonobese pregnant women.
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